close

Enter

Log in using OpenID

Muscular Dystrophy Treatment Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

embed
Muscular Dystrophy is characterized by a collection of muscle-wasting conditions. The disorder is caused by genetic mutations which interfere with the production of muscle protein dystrophin, necessary to build muscles. Muscular dystrophy is a genet
MUSCULAR DYSTROPHY
TREATMENT MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2017– 2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Muscular Dystrophy Treatment Market Overview
Muscular Dystrophy is characterized by a collection of muscle-wasting conditions. The disorder
is caused by genetic mutations which interfere with the production of muscle protein
dystrophin, necessary to build muscles. Muscular dystrophy is a genetic disease, consequently,
the chance of an individual developing a disease increases with a history of muscular dystrophy
in the family. The symptoms include shortening of muscles and tendons, the curvature of spine,
weakening of heart muscles leading to cardiac problems, and breathing problems. The most
common forms of muscular dystrophies include duchenne muscular dystrophy, becker muscular
dystrophy, myotonic disease, congenital disease and oculopharyngeal muscular dystrophy. The
cure for any form of muscular dystrophy is currently unspecified, but the symptoms can be
relived through physical therapy, exercise, rehabilitative devices like a powered wheelchair,
respiratory care and surgery.
Request to download and view Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/914
Rising prevalence of muscular dystrophies with unspecific current medications is expected to
fuel the muscular dystrophies treatment market
According to the research conducted by the Karger Journal on 2014, the global prevalence for
muscular dystrophies accounted between 19.8 and 25.1 per 100,000 person every year with
myotonic dystrophy (0.5-18.1 per 100,000), duchenne muscular dystrophy (1.7-4.2) and
facioscapulohumeral muscular dystrophy (3.2-4.6 per 100,000) to be the most common types of
disorders.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
The common muscular dystrophy types:
Duchenne muscular dystrophy (DMD)
Most common form of muscular dystrophy in children caused by lack of protein dystrophin. The onset of symptoms is
seen at the age of 3, generally wheelchair-bound by 12. The Curvature in spine, heart, and lungs effects are the
symptoms. Duchenne muscular dystrophy (DMD) is an X-linked disease predominantly affecting males, resulting in
uniform muscle wasting. Death occurs due to respiratory failure by mid-twenties.
Becker muscular dystrophy(BMD)
Similar to Duchenne, however, with later onset and slow progression of the illness. Death occurs in the mid-forties.
Oculopharyngeal muscular dystrophy(OMD)
Initially affect eyelids, throat, and face followed by pelvis and shoulder. The onset of illness is seen between the ages
40 and 50.
Myotonic muscular dystrophy(MSD)
Most common form of muscular dystrophy in adults also called as Steinert's disease. Characterized by the inability of
muscles to relax after contraction. Cataracts, insomnia, and arrhythmia are the symptoms.
Congenital muscular dystrophy (CMD)
The disease prevails from birth or before the age of 2. Significant impairment is caused by a swift progression of the
disease. Congenital muscular dystrophy (CMD) causes learning disabilities and mental retardation.
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/914
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Specific guidance by FDA is expected to dominate North America the global market
Regional segmentation of the global muscular dystrophy treatment market by Coherent Market
Insights comprises North America, Latin America, Europe, Asia-Pacific and The Middle East and
Africa. According to the Centers for Disease Control and Prevention estimates in 2007, 349 out
of 2.37 million males aged 5 to 24 years were reported to have duchenne muscular
dystrophy or becker muscular dystrophy in the United States. North America is expected to
dominate the global muscular dystrophy treatment market owing to the absence of marketed
pharmacological therapies indicated to treat muscular dystrophy, rising prevalence of the
disease and rising research and development for producing effective drugs. Europe is expected
to boost the market share in the forecast period with the growing public awareness and
increasing research activities.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/914
Launch of efficient corticosteroids to rise the market demand
The key players operating the global muscular dystrophy treatment market include Santhera
Pharmaceuticals, PTC Therapeutics, BioMarin Pharmaceutical, Sarepta Therapeutics and Eli
Lilly. The approval and launch of oral corticosteroid Emflaza in 2017, has been found highly
effective in patients to regain strength and restore their ability to walk. The other vendors
include Acceleron Pharma, Capricor Therapeutics, Bristol-Myers Squibb, Lexicon
Pharmaceuticals, and Pfizer.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved
1/--pages
Report inappropriate content